Retracted: Bisindole-oxadiazole hybrids, T3P mediated -synthesis and appraisal of their apoptotic, antimetastatic and computational Bcl-2 binding potential.

Clicks: 432
ID: 20149
2018
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #5 of 52 articles by views in Journal of biochemical and molecular toxicology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Retraction: Kamath PR, Joseph MM, Ajees AA, et al. Bisindole-oxadiazole hybrids, T3P mediated synthesis and appraisal of their apoptotic, antimetastatic and computational Bcl-2 binding potential. J Biochem Mol Toxicol. 2017;31:e21962. https://doi.org/10.1002/jbt.21962 The above article from the Journal of Biochemical and Molecular Toxicology, published online on 19 July 2017 in Wiley Online Library (https://onlinelibrary.wiley.com/doi/abs/10.1002/jbt.21962) and in Volume 31, Issue 11, has been retracted by agreement of the Journal Editor-in-Chief, Dr Hari Bhat, and Wiley Periodicals, Inc. The retraction has been agreed due to the absence of access to the original data needed to answer questions about the reliability of some of the findings presented in the paper.
Reference Key
nolastname2018retractedjournal Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal Journal of biochemical and molecular toxicology
Year 2018
DOI
10.1002/jbt.22212
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.